OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. Various strategies have here been employed enhance antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion technologies. Fine-tuning growth pa